A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)

PHASE2UnknownINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

June 30, 2016

Conditions

Recurrent Pregnancy LossRecurrent Miscarriage

Interventions

DRUG

NT100

DRUG

Placebo

Trial Locations (19)

Ashington

Birmingham

Chertsey, Surrey

Coventry

Edinburgh

Frimley, Surrey

Leeds

Liverpool

London

Manchester

Middlesbrough

Newcastle upon Tyne

Nottingham

Oxford

Plymouth

South Shields

Southamptom

Stoke-on-Trent

Sunderland